VIVUS (VVUS) to Report Q1 Results May 8th; Focus on Promotions vs. New Rx
Tweet Send to a Friend
Following Arena Pharmaceutical's (Nasdaq: ARNA) Q1 results and plans to pull its MAA for BELVIQ from Europe (which may have ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
